Starling Oncology, Inc. (STLNW) Net margin 2020–2025
Starling Oncology, Inc. (STLNW) net profit margin by fiscal year — reported net income divided by reported revenue.
-12.1%FY2025 · since FY2020: -7.6% → -12.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -12.1% | +4.4 pp |
| FY2024 | -16.4% | +9.2 pp |
| FY2023 | -25.6% | -25.7 pp |
| FY2022 | 0.1% | +5.4 pp |
| FY2021 | -5.4% | +2.3 pp |
| FY2020 | -7.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice